Publicaciones en colaboración con investigadores/as de Hospital Universitario Puerta de Hierro (56)

2024

  1. Combinational Diuretics in Heart Failure

    Current Heart Failure Reports, Vol. 21, Núm. 4, pp. 1-11

  2. Consensus on the approach to hydrosaline overload in acute heart failure. SEMI/SEC/S.E.N. recommendations

    Revista Espanola de Cardiologia, Vol. 77, Núm. 7, pp. 556-565

  3. Mesenchymal stromal cell therapy for COVID-19 acute respiratory distress syndrome: a double-blind randomised controlled trial

    Bone Marrow Transplantation, Vol. 59, Núm. 6, pp. 777-784

  4. Practical Approaches to the Management of Cardiorenal Disease beyond Congestion

    Cardiorenal medicine, Vol. 14, Núm. 1, pp. 235-250

  5. Real-world safety and effectiveness of dapagliflozin in people living with type 1 diabetes in Spain: The Dapa-ON multicenter retrospective study

    Diabetes and Metabolism, Vol. 50, Núm. 1

2023

  1. Cardiogenic shock code 2023. Expert document for a multidisciplinary organization that allows quality care

    Revista Espanola de Cardiologia, Vol. 76, Núm. 4, pp. 261-269

  2. Hyperthermic Mitomycin C in Intermediate-risk Non-muscle-invasive Bladder Cancer: Results of the HIVEC-1 Trial

    European urology oncology, Vol. 6, Núm. 1, pp. 58-66

  3. Real-life safety and effectiveness outcomes of teriflunomide in patients with relapsing–remitting multiple sclerosis: The TERICAM study

    Neurology Perspectives, Vol. 3, Núm. 4

2022

  1. Baseline Inflammatory Status Reveals Dichotomic Immune Mechanisms Involved In Primary-Progressive Multiple Sclerosis Pathology

    Frontiers in immunology, Vol. 13, pp. 842354

  2. Early predictive risk factors for dimethyl fumarate-associated lymphopenia in patients with multiple sclerosis

    Multiple Sclerosis and Related Disorders, Vol. 59

  3. Efficacy and Safety of the Hexanic Extract of Serenoa repens vs. Watchful Waiting in Men with Moderate to Severe LUTS-BPH: Results of a Paired Matched Clinical Study

    Journal of Clinical Medicine, Vol. 11, Núm. 4

  4. Efficacy and Tolerability of 6-Month Treatment with Tamsulosin Plus the Hexanic Extract of Serenoa repens versus Tamsulosin Plus 5-Alpha-Reductase Inhibitors for Moderate-to-Severe LUTS-BPH Patients: Results of a Paired Matched Clinical Study

    Journal of Clinical Medicine, Vol. 11, Núm. 13

  5. Endocannabinoid levels in peripheral blood mononuclear cells of multiple sclerosis patients treated with dimethyl fumarate

    Scientific Reports, Vol. 12, Núm. 1

  6. Impact of different COVID-19 waves on kidney replacement therapy epidemiology and mortality: REMER 2020

    Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, Vol. 37, Núm. 11, pp. 2253-2263

  7. Impact of renal function on the prognostic value of mineral metabolism in patients with chronic ischaemic heart disease patients with chronic ischaemic heart disease

    Clinica e Investigacion en Arteriosclerosis, Vol. 34, Núm. 1, pp. 1-9

2021

  1. Cancer diagnosis in a Spanish cohort of multiple sclerosis patients under dimethylfumarate treatment

    Multiple Sclerosis and Related Disorders, Vol. 49

  2. Demographic, clinical, and functional determinants of antithrombotic treatment in patients with nonvalvular atrial fibrillation

    BMC Cardiovascular Disorders, Vol. 21, Núm. 1

  3. Double-blind, randomized, controlled, trial to assess the efficacy of allogenic mesenchymal stromal cells in patients with acute respiratory distress syndrome due to COVID-19 (COVID-AT): A structured summary of a study protocol for a randomised controlled trial

    Trials

  4. Efficacy and tolerability of the hexanic extract of Serenoa repens compared to tamsulosin in moderate-severe LUTS-BPH patients

    Scientific Reports, Vol. 11, Núm. 1

  5. Initiation and titration of sacubitril/valsartan in different types of centers

    REC: CardioClinics, Vol. 56, Núm. 2, pp. 92-97